Application Sponsors
ANDA 090061 | HETERO LABS LTD III | |
Marketing Status
Application Products
001 | TABLET;ORAL | 5MG | 0 | FINASTERIDE | FINASTERIDE |
FDA Submissions
| ORIG | 1 | AP | 2010-06-07 | |
LABELING; Labeling | SUPPL | 3 | AP | 2012-02-14 | |
LABELING; Labeling | SUPPL | 5 | AP | 2013-02-22 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2013-04-26 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2015-04-06 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 2015-04-06 | UNKNOWN |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 2015-03-19 | UNKNOWN |
LABELING; Labeling | SUPPL | 17 | AP | 2022-03-11 | STANDARD |
LABELING; Labeling | SUPPL | 18 | AP | 2022-03-11 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 3 | Null | 15 |
SUPPL | 5 | Null | 15 |
SUPPL | 6 | Null | 15 |
SUPPL | 8 | Null | 15 |
SUPPL | 9 | Null | 7 |
SUPPL | 10 | Null | 7 |
SUPPL | 17 | Null | 15 |
SUPPL | 18 | Null | 15 |
TE Codes
CDER Filings
HETERO LABS LTD III
cder:Array
(
[0] => Array
(
[ApplNo] => 90061
[companyName] => HETERO LABS LTD III
[docInserts] => ["",""]
[products] => [{"drugName":"FINASTERIDE","activeIngredients":"FINASTERIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"FINASTERIDE","submission":"FINASTERIDE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)